The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it blocks heterodimerization of HER2 with other HER receptors, slowing tumor growth.
The global Pertuzumab market was valued at US$ 152 million in 2023 and is anticipated to reach US$ 372.4 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Pertuzumab, in combination with trastuzumab, is used in HER2-positive breast cancer treatment. Market trends include its continued use in combination therapies and ongoing clinical trials to explore its potential in other cancer types.
This report aims to provide a comprehensive presentation of the global market for Pertuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertuzumab.
Report Scope
The Pertuzumab market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertuzumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertuzumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Segment by Type
Human Source
Animal Source
Segment by Application
Hospital
Medical Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pertuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pertuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it blocks heterodimerization of HER2 with other HER receptors, slowing tumor growth.
The global Pertuzumab market was valued at US$ 152 million in 2023 and is anticipated to reach US$ 372.4 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Pertuzumab, in combination with trastuzumab, is used in HER2-positive breast cancer treatment. Market trends include its continued use in combination therapies and ongoing clinical trials to explore its potential in other cancer types.
This report aims to provide a comprehensive presentation of the global market for Pertuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertuzumab.
Report Scope
The Pertuzumab market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertuzumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertuzumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Segment by Type
Human Source
Animal Source
Segment by Application
Hospital
Medical Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pertuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pertuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pertuzumab Market Overview
1.1 Product Overview and Scope of Pertuzumab
1.2 Pertuzumab Segment by Type
1.2.1 Global Pertuzumab Market Value Comparison by Type (2024-2030)
1.2.2 Human Source
1.2.3 Animal Source
1.3 Pertuzumab Segment by Application
1.3.1 Global Pertuzumab Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Global Pertuzumab Market Size Estimates and Forecasts
1.4.1 Global Pertuzumab Revenue 2019-2030
1.4.2 Global Pertuzumab Sales 2019-2030
1.4.3 Global Pertuzumab Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pertuzumab Market Competition by Manufacturers
2.1 Global Pertuzumab Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pertuzumab Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pertuzumab Average Price by Manufacturers (2019-2024)
2.4 Global Pertuzumab Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pertuzumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pertuzumab, Product Type & Application
2.7 Pertuzumab Market Competitive Situation and Trends
2.7.1 Pertuzumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pertuzumab Players Market Share by Revenue
2.7.3 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pertuzumab Retrospective Market Scenario by Region
3.1 Global Pertuzumab Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pertuzumab Global Pertuzumab Sales by Region: 2019-2030
3.2.1 Global Pertuzumab Sales by Region: 2019-2024
3.2.2 Global Pertuzumab Sales by Region: 2025-2030
3.3 Global Pertuzumab Global Pertuzumab Revenue by Region: 2019-2030
3.3.1 Global Pertuzumab Revenue by Region: 2019-2024
3.3.2 Global Pertuzumab Revenue by Region: 2025-2030
3.4 North America Pertuzumab Market Facts & Figures by Country
3.4.1 North America Pertuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pertuzumab Sales by Country (2019-2030)
3.4.3 North America Pertuzumab Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pertuzumab Market Facts & Figures by Country
3.5.1 Europe Pertuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pertuzumab Sales by Country (2019-2030)
3.5.3 Europe Pertuzumab Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pertuzumab Market Facts & Figures by Country
3.6.1 Asia Pacific Pertuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pertuzumab Sales by Country (2019-2030)
3.6.3 Asia Pacific Pertuzumab Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pertuzumab Market Facts & Figures by Country
3.7.1 Latin America Pertuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pertuzumab Sales by Country (2019-2030)
3.7.3 Latin America Pertuzumab Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pertuzumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Pertuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pertuzumab Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pertuzumab Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pertuzumab Sales by Type (2019-2030)
4.1.1 Global Pertuzumab Sales by Type (2019-2024)
4.1.2 Global Pertuzumab Sales by Type (2025-2030)
4.1.3 Global Pertuzumab Sales Market Share by Type (2019-2030)
4.2 Global Pertuzumab Revenue by Type (2019-2030)
4.2.1 Global Pertuzumab Revenue by Type (2019-2024)
4.2.2 Global Pertuzumab Revenue by Type (2025-2030)
4.2.3 Global Pertuzumab Revenue Market Share by Type (2019-2030)
4.3 Global Pertuzumab Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pertuzumab Sales by Application (2019-2030)
5.1.1 Global Pertuzumab Sales by Application (2019-2024)
5.1.2 Global Pertuzumab Sales by Application (2025-2030)
5.1.3 Global Pertuzumab Sales Market Share by Application (2019-2030)
5.2 Global Pertuzumab Revenue by Application (2019-2030)
5.2.1 Global Pertuzumab Revenue by Application (2019-2024)
5.2.2 Global Pertuzumab Revenue by Application (2025-2030)
5.2.3 Global Pertuzumab Revenue Market Share by Application (2019-2030)
5.3 Global Pertuzumab Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Pertuzumab Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis AG Pertuzumab Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pertuzumab Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Pertuzumab Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Abnova Corporation
6.3.1 Abnova Corporation Corporation Information
6.3.2 Abnova Corporation Description and Business Overview
6.3.3 Abnova Corporation Pertuzumab Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abnova Corporation Pertuzumab Product Portfolio
6.3.5 Abnova Corporation Recent Developments/Updates
6.4 InvivoGen
6.4.1 InvivoGen Corporation Information
6.4.2 InvivoGen Description and Business Overview
6.4.3 InvivoGen Pertuzumab Sales, Revenue and Gross Margin (2019-2024)
6.4.4 InvivoGen Pertuzumab Product Portfolio
6.4.5 InvivoGen Recent Developments/Updates
6.5 Celltrion
6.5.1 Celltrion Corporation Information
6.5.2 Celltrion Description and Business Overview
6.5.3 Celltrion Pertuzumab Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Celltrion Pertuzumab Product Portfolio
6.5.5 Celltrion Recent Developments/Updates
6.6 Biocon Limited
6.6.1 Biocon Limited Corporation Information
6.6.2 Biocon Limited Description and Business Overview
6.6.3 Biocon Limited Pertuzumab Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biocon Limited Pertuzumab Product Portfolio
6.6.5 Biocon Limited Recent Developments/Updates
6.7 Bio-Techne
6.6.1 Bio-Techne Corporation Information
6.6.2 Bio-Techne Description and Business Overview
6.6.3 Bio-Techne Pertuzumab Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Techne Pertuzumab Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pertuzumab Industry Chain Analysis
7.2 Pertuzumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pertuzumab Production Mode & Process
7.4 Pertuzumab Sales and Marketing
7.4.1 Pertuzumab Sales Channels
7.4.2 Pertuzumab Distributors
7.5 Pertuzumab Customers
8 Pertuzumab Market Dynamics
8.1 Pertuzumab Industry Trends
8.2 Pertuzumab Market Drivers
8.3 Pertuzumab Market Challenges
8.4 Pertuzumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pertuzumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pertuzumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pertuzumab Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pertuzumab Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Pertuzumab Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pertuzumab Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pertuzumab Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pertuzumab Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pertuzumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pertuzumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pertuzumab, Product Type & Application
Table 12. Global Key Manufacturers of Pertuzumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pertuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertuzumab as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pertuzumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pertuzumab Sales by Region (2019-2024) & (MT)
Table 18. Global Pertuzumab Sales Market Share by Region (2019-2024)
Table 19. Global Pertuzumab Sales by Region (2025-2030) & (MT)
Table 20. Global Pertuzumab Sales Market Share by Region (2025-2030)
Table 21. Global Pertuzumab Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pertuzumab Revenue Market Share by Region (2019-2024)
Table 23. Global Pertuzumab Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pertuzumab Revenue Market Share by Region (2025-2030)
Table 25. North America Pertuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pertuzumab Sales by Country (2019-2024) & (MT)
Table 27. North America Pertuzumab Sales by Country (2025-2030) & (MT)
Table 28. North America Pertuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pertuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pertuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pertuzumab Sales by Country (2019-2024) & (MT)
Table 32. Europe Pertuzumab Sales by Country (2025-2030) & (MT)
Table 33. Europe Pertuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pertuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pertuzumab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pertuzumab Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Pertuzumab Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Pertuzumab Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pertuzumab Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pertuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pertuzumab Sales by Country (2019-2024) & (MT)
Table 42. Latin America Pertuzumab Sales by Country (2025-2030) & (MT)
Table 43. Latin America Pertuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pertuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pertuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pertuzumab Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Pertuzumab Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Pertuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pertuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pertuzumab Sales (MT) by Type (2019-2024)
Table 51. Global Pertuzumab Sales (MT) by Type (2025-2030)
Table 52. Global Pertuzumab Sales Market Share by Type (2019-2024)
Table 53. Global Pertuzumab Sales Market Share by Type (2025-2030)
Table 54. Global Pertuzumab Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pertuzumab Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pertuzumab Revenue Market Share by Type (2019-2024)
Table 57. Global Pertuzumab Revenue Market Share by Type (2025-2030)
Table 58. Global Pertuzumab Price (USD/MT) by Type (2019-2024)
Table 59. Global Pertuzumab Price (USD/MT) by Type (2025-2030)
Table 60. Global Pertuzumab Sales (MT) by Application (2019-2024)
Table 61. Global Pertuzumab Sales (MT) by Application (2025-2030)
Table 62. Global Pertuzumab Sales Market Share by Application (2019-2024)
Table 63. Global Pertuzumab Sales Market Share by Application (2025-2030)
Table 64. Global Pertuzumab Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pertuzumab Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pertuzumab Revenue Market Share by Application (2019-2024)
Table 67. Global Pertuzumab Revenue Market Share by Application (2025-2030)
Table 68. Global Pertuzumab Price (USD/MT) by Application (2019-2024)
Table 69. Global Pertuzumab Price (USD/MT) by Application (2025-2030)
Table 70. Novartis AG Corporation Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Novartis AG Pertuzumab Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Pfizer Pertuzumab Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Abnova Corporation Corporation Information
Table 81. Abnova Corporation Description and Business Overview
Table 82. Abnova Corporation Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Abnova Corporation Pertuzumab Product
Table 84. Abnova Corporation Recent Developments/Updates
Table 85. InvivoGen Corporation Information
Table 86. InvivoGen Description and Business Overview
Table 87. InvivoGen Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. InvivoGen Pertuzumab Product
Table 89. InvivoGen Recent Developments/Updates
Table 90. Celltrion Corporation Information
Table 91. Celltrion Description and Business Overview
Table 92. Celltrion Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Celltrion Pertuzumab Product
Table 94. Celltrion Recent Developments/Updates
Table 95. Biocon Limited Corporation Information
Table 96. Biocon Limited Description and Business Overview
Table 97. Biocon Limited Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Biocon Limited Pertuzumab Product
Table 99. Biocon Limited Recent Developments/Updates
Table 100. Bio-Techne Corporation Information
Table 101. Bio-Techne Description and Business Overview
Table 102. Bio-Techne Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Bio-Techne Pertuzumab Product
Table 104. Bio-Techne Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Pertuzumab Distributors List
Table 108. Pertuzumab Customers List
Table 109. Pertuzumab Market Trends
Table 110. Pertuzumab Market Drivers
Table 111. Pertuzumab Market Challenges
Table 112. Pertuzumab Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pertuzumab
Figure 2. Global Pertuzumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pertuzumab Market Share by Type in 2023 & 2030
Figure 4. Human Source Product Picture
Figure 5. Animal Source Product Picture
Figure 6. Global Pertuzumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pertuzumab Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Medical Center
Figure 10. Global Pertuzumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pertuzumab Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pertuzumab Sales (2019-2030) & (MT)
Figure 13. Global Pertuzumab Average Price (USD/MT) & (2019-2030)
Figure 14. Pertuzumab Report Years Considered
Figure 15. Pertuzumab Sales Share by Manufacturers in 2023
Figure 16. Global Pertuzumab Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Pertuzumab Players: Market Share by Revenue in 2023
Figure 18. Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Pertuzumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pertuzumab Sales Market Share by Country (2019-2030)
Figure 21. North America Pertuzumab Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pertuzumab Sales Market Share by Country (2019-2030)
Figure 25. Europe Pertuzumab Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pertuzumab Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pertuzumab Revenue Market Share by Region (2019-2030)
Figure 33. China Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Pertuzumab Sales Market Share by Country (2019-2030)
Figure 44. Latin America Pertuzumab Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Pertuzumab Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Pertuzumab Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Pertuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Pertuzumab by Type (2019-2030)
Figure 54. Global Revenue Market Share of Pertuzumab by Type (2019-2030)
Figure 55. Global Pertuzumab Price (USD/MT) by Type (2019-2030)
Figure 56. Global Sales Market Share of Pertuzumab by Application (2019-2030)
Figure 57. Global Revenue Market Share of Pertuzumab by Application (2019-2030)
Figure 58. Global Pertuzumab Price (USD/MT) by Application (2019-2030)
Figure 59. Pertuzumab Value Chain
Figure 60. Pertuzumab Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
